PERSPECTA

News from every angle

← Back to headlines

Revolution Medicines Reports Widened Net Loss Amid Clinical Trial Progress

Revolution Medicines, Inc. announced an increase in its net loss, despite making advancements in its ongoing clinical trial programs.

2 Mar, 07:57 — 2 Mar, 07:57
PostShare
Only 1 source covers this story